StonvexLoading…
StonvexStonvexStonvexCore line items from TMUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $88.31B | $81.40B | $78.56B | $79.57B |
Operating Income | $18.28B | $18.01B | $14.27B | $6.54B |
Net Income | $10.99B | $11.34B | $8.32B | $2.59B |
EPS (Diluted) | $9.72 | $9.66 | $6.93 | $2.06 |
Total Assets | $219.24B | $208.03B | $207.68B | $211.34B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.60B | $5.41B | $5.13B | $4.51B |
Free Cash Flow OCF − CapEx | $18.00B | $13.45B | $8.76B | $2.81B |
Shares Outstanding | 1.11B | 1.14B | 1.20B | 1.23B |